Showing 5011-5020 of 5646 results for "".
- My Eyelab and Stanton Optical Shifts to Solely Telehealth Eyecare to Serve Communityhttps://modernod.com/news/my-eyelab-and-stanton-optical-shifts-to-solely-telehealth-eyecare-to-serve-community/2477426/My Eyelab and Stanton Optical, retail brands of Now Optics will immediately be switching to virtual eye care at 119 participating locations across the nation. In partnership with the Physicians Eyecare Group, select locations will offer patients the opportunity to receive eye care through telemed
- First-Phase Clinical Trials of China’s First Covid-19 Vaccine to Last Nine Monthshttps://modernod.com/news/first-phase-clinical-trials-of-chinas-first-covid-19-vaccine-to-last-nine-months/2477423/Clinical trials of China’s first inoculation for Covid-19 will run until Dec. 31 this year, according to data made public by the Chinese Clinical Trial Registry, as rep
- HIV Drug Failed to Help Patients With Severe Cases of COVID-19https://modernod.com/news/hiv-drug-failed-to-help-patients-with-severe-cases-of-covid-19/2477425/A potential coronavirus treatment has failed in a randomized clinical trial in China. A group of Chinese researchers tested the HIV drug Kaletra in a group of patients with severe cases of COVID-19, the disease caused by the novel coronavirus, according to a
- The Coronavirus Crisis: What Companies Need to Know About Congressional Actions to Datehttps://modernod.com/news/the-coronavirus-crisis-what-companies-need-to-know-about-congressional-actions-to-date/2477419/As the coronavirus grew to pandemic status last week, Congress snapped into action with two major pieces of legislation designed for government agencies to help individuals affected by the crisis. In the weeks ahead, Congress will consider a series of extraordinary legislative measures needed to
- Topcon Announces Customer Initiatives to Combat Global COVID-19 Crisishttps://modernod.com/news/topcon-announces-customer-initiatives-to-combat-global-covid-19-crisis/2477421/As the COVID-19 pandemic continues to escalate across the globe, Topcon Healthcare has announced a series of initiatives and programs designed to support its customers during this time of unprecedented challenges. As healthcare providers, eye doctors are required to be in close contact wit
- Trump Touts Drug That FDA Says Isn’t Yet Approved for Virushttps://modernod.com/news/trump-touts-drug-that-fda-says-isnt-yet-approved-for-virus/2477422/The Food and Drug Administration has been told by President Donald Trump to see if it can expand the use of a decades-old malaria drug as an experimental treatment for coronavirus patients, as
- Retina Specialists Share How They Are Adjusting to COVID-19https://modernod.com/news/retina-specialists-share-how-they-are-adjusting-to-covid-19/2477416/As the novel coronavirus outbreak continues to spread in the United States, retina clinics—who often see older patients who are more at risk of virus complications—are making a number of adjustments. Rishi P. Singh, MD, staff physician at the Cole Eye Institute at the Cleveland Clinic, whe
- Roche Initiates Phase 3 Trial of Actemra/RoActemra in Patients With Severe COVID-19 Pneumoniahttps://modernod.com/news/roche-initiates-phase-3-trial-of-actemra-roactemra-in-patients-with-severe-covid-19-pneumonia/2477410/Roche announced it is working with the FDA to initiate a randomized, double-blind, placebo-controlled phase 3 clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of th
- Chinese Official Claims Fujifilm’s Avigan “Clearly Effective” in Treating COVID-19https://modernod.com/news/chinese-official-claims-fujifilms-avigan-clearly-effective-in-treating-covid-19/2477411/Results of clinical studies conducted in China suggest that Fujifilm’s Avigan (favipiravir) may be effective at treating patients with COVID-19. Zhang Xinmin, director of the China National Center for Biotechnology Development under the Ministry of Science and Technology, remarked “it
- Quidel Receives Emergency Use Authorization for Molecular COVID-19 Diagnostic Assayhttps://modernod.com/news/quidel-receives-emergency-use-authorization-for-molecular-covid-19-diagnostic-assay/2477407/Quidel, a provider of rapid diagnostic testing solutions, announced that the company has received Emergency Use Authorization (EUA) from the FDA to market its Lyra SARS-CoV-2 Assay, a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or